Malignant hyperthermia (MH) is a potentially fatal inherited pharmacogenetic disorder
related to pathogenic variants in the RYR1, CACNA1S, or STAC3 genes. Early recognition …

The increasing amount of information delineating the descriptions of movement disorders
emergencies provides means for more effective prevention, identification, and management …

Background Local anesthetic systemic toxicity (LAST) is a rare and potentially devastating
complication of regional anesthesia. Single-institution registries have reported a decreasing …

Abstract Editor's Perspective What We Already Know about This Topic Malignant
hyperthermia is a rare life-threatening disorder triggered in genetically predisposed …

BACKGROUND: Discharge diagnoses are used to track national trends and patterns of
maternal morbidity. There are few data regarding the validity of the International …

BACKGROUND The use of large national databases for clinical research has increased
recently in the field of trauma care as they allow study of rare events without the logistical …

Purpose Malignant hyperthermia (MH) is a rare but fatal pharmacogenetic disorder,
triggered by inhalational anesthetics or succinylcholine. Since the first nonprofit academic …

Study objective Malignant hyperthermia (MH) is a rare yet potentially fatal pharmacogenetic
disorder triggered by exposure to inhalational anesthetics and the depolarizing …

BACKGROUND: Malignant hyperthermia (MH) is a rare yet potentially fatal
pharmacogenetic disorder triggered by exposure to inhaled anesthetics and the …

Background Perioperative aspiration is a rare but potentially devastating complication,
occurring in 1‐10 per 10 000 anesthetics based on studies of quality assurance databases …